High affinity is insufficient for strong B cell activation by HIV broadly neutralising antibodies

Abstract HIV broadly neutralizing antibodies (bnAbs) have been widely studied, and inducing a robust broadly neutralizing response remains a goal for many human vaccine studies. Much research focusses on creating higher affinity antigens to target bnAb precursors, however this ignores the role of no...

Descripción completa

Detalles Bibliográficos

Autores principales:	Chloe Rees-Spear, Olivia Payne, Emma Touizer, Alan Kennedy, Luke Muir, Peter Thomas, Alyssa Thomas DeCruz, Rachel A. McKendry, Leo Swadling, Marit J. van Gils, James E. Voss, Laura E. McCoy
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Nature Portfolio 2026-05-01
Colección:	npj Vaccines
Acceso en línea:	https://doi.org/10.1038/s41541-026-01468-y
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!